(Q34985833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

review article

1 reference

title

Switching effective antiretroviral therapy: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

main subject

anti-retroviral agent

0 references

author

William G Powderly

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Henning Drechsler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

English

0 references

publication date

21 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1219-1230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410482%20AND%20SRC:MED&resulttype=core&format=json

A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection

14 December 2019

cites work

1 reference

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA.

21 January 2018

1 reference

Changes in metabolic parameters and body shape after replacement of protease inhibitor With efavirenz in virologically controlled HIV-1-positive persons: single-arm observational cohort

21 January 2018

1 reference

Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy.

21 January 2018

1 reference

Switch to efavirenz in a protease inhibitor-containing regimen

21 January 2018

1 reference

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine

21 January 2018

1 reference

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

21 January 2018

1 reference

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

21 January 2018

1 reference

Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial

21 January 2018

1 reference

A simple measure of insulin resistance

21 January 2018

1 reference

Changes in AIDS incidence for men who have sex with men, United States 1990-1995.

21 January 2018

1 reference

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

21 January 2018

1 reference

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

21 January 2018

1 reference

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

Mitochondrial toxicity hypothesis for lipoatrophy: a refutation

21 January 2018

1 reference

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

21 January 2018

1 reference

A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient

21 January 2018

1 reference

Fat distribution and metabolic changes in patients with HIV infection

21 January 2018

1 reference

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

21 January 2018

1 reference